Detalhe da pesquisa
1.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 22(6): 813-823, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34000245
2.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33740099
3.
Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.
Oncologist
; 24(11): e1102-e1107, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30936377
4.
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.
Lancet
; 390(10103): 1645-1653, 2017 Oct 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28801186
5.
Health-related quality of life associated with regorafenib treatment in refractory advanced gastric adenocarcinoma.
Gastric Cancer
; 21(3): 473-480, 2018 May.
Artigo
Inglês
| MEDLINE | ID: mdl-28815316
6.
Successful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocarditis secondary to nivolumab therapy.
Br J Cancer
; 117(7): 921-924, 2017 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-28797029
7.
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study.
Lancet Gastroenterol Hepatol
; 7(10): 943-951, 2022 10.
Artigo
Inglês
| MEDLINE | ID: mdl-35803294
8.
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial.
Clin Cancer Res
; 28(12): 2527-2535, 2022 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-35275197
9.
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
Neuro Oncol
; 23(9): 1547-1559, 2021 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33914057
10.
A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.
Clin Cancer Res
; 13(11): 3286-92, 2007 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17545534
11.
Targeted chemoradiation in metastatic colorectal cancer: a phase I trial of 131I-huA33 with concurrent capecitabine.
J Nucl Med
; 55(4): 534-9, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24556590
12.
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.
Proc Natl Acad Sci U S A
; 104(10): 4071-6, 2007 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-17360479